Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

por Bartlett, J B, Tozer, A, Stirling, D, Zeldis, J B
Publicado 2005

Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care

por Hallowell, Nina, Wright, S., Stirling, D., Gourley, C., Young, O., Porteous, M.
Publicado 2019

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

por Dredge, K, Marriott, J B, Macdonald, C D, Man, H-W, Chen, R, Muller, G W, Stirling, D, Dalgleish, A G
Publicado 2002

High-content microscopy reveals a morphological signature of bortezomib resistance

por Kelley, M.E., Berman, A.Y., Stirling, D.R., Cimini, B.A., Han, Y., Singh, S., Carpenter, A.E., Kapoor, T.M., Way, G.P.
Publicado 2023

Vaccines for COVID‐19

por Tregoning, J. S., Brown, E. S., Cheeseman, H. M., Flight, K. E., Higham, S. L., Lemm, N.‐M., Pierce, B. F., Stirling, D. C., Wang, Z., Pollock, K. M.
Publicado 2020

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced...

por Bartlett, J B, Michael, A, Clarke, I A, Dredge, K, Nicholson, S, Kristeleit, H, Polychronis, A, Pandha, H, Muller, G W, Stirling, D I, Zeldis, J, Dalgleish, A G
Publicado 2004

Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold

por Anderson, E, Berg, J, Black, R, Bradshaw, N, Campbell, J, Carnaghan, H, Cetnarkyj, R, Drummond, S, Davidson, R, Dunlop, J, Fordyce, A, Gibbons, B, Goudie, D, Gregory, H, Holloway, S, Longmuir, M, McLeish, L, Murday, V, Miedzybrodska, Z, Nicholson, D, Pearson, P, Porteous, M, Reis, M, Slater, S, Smith, K, Smyth, E, Snadden, L, Steel, M, Stirling, D, Watt, C, Whyte, C, Young, D
Publicado 2008